Head of Investor Relations
Coherus Oncology, Inc. (CHRS)Head of Investor Relations
Revolution Medicines, Inc. (RVMD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
David Arrington is recorded as Head of Investor Relations at Coherus Oncology, Inc. (CHRS) and Head of Investor Relations at Revolution Medicines, Inc. (RVMD). David Arrington has spoken on 1 earnings call across 1 company, most recently for Coherus Oncology, Inc. on August 6, 2020.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Recorded roles and call appearances connecting this person to public companies.
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
